Queensland Statewide Antimicrobial Stewardship Program
The Queensland Statewide Antimicrobial Stewardship Program is a multidisciplinary team consisting of: Infectious Diseases physicians, pharmacists and nurses.
The goal of the Program is to unite Queenslanders to enhance the use of antimicrobials now and to preserve them for future generations by advancing clinical practice, education and research.
We offer education, training and connections with other antimicrobial stewardship programs across the Hospital and Health Services (HHSs).
Contact the AMS Program
- Email statewide.AMS@health.qld.gov.au
- Phone (07) 3646 1886
- Visit our Yammer site for updates and resources.
We offer a variety of activities including:
- Skills Sessions: AMS Quality Improvement Skills Sessions and Complex Case Skills Sessions
- Educational Lecture Series: Infectious Diseases Basics Stream , Pharmacokinetics, Pharmacodynamics and Therapeutic Drug Monitoring Stream
- Showcase and Literature Review series: AMS Strategies in Practice.
These sessions will be repeated across 4 main themes:
- respiratory syndromes
- intra-abdominal infections and
- skin and soft tissue infections.
Videoconference access is available for all Queensland Health and external participants. Details will be provided for each session.
Meet the team
The AMS Program is a multidisciplinary team made up of infectious diseases physicians, pharmacists and nurses:
Dr Krispin Hajkowicz, FRACP, MPH – Director – is a Senior Staff Specialist in Infectious Diseases at Royal Brisbane and Women’s Hospital and a Senior Lecturer in the School of Medicine, University of Queensland. He has extensive experience in the development and delivery of antimicrobial stewardship programs, education on quality antimicrobial use and research in antimicrobial resistance and stewardship.
Dr Kathryn Daveson, MBBS, MPH, FRACP – Staff Specialist Infectious Diseases Physician – is a Staff Specialist in Infectious Diseases working clinically within infectious diseases as well as tertiary hospital based antimicrobial stewardship programs across two health jurisdictions. Her special interests are in antimicrobial stewardship, health economics, antibiotic pharmacokinetics and pharmacodynamics, mycology and telehealth in medicine with a particular interest in resistance, hospital associated infections and infections in the immunocompromised host.
|Dr Minyon Avent, B Pharm, B Sc (Hons), Pharm D, BCPS, FSHP, Adv. Prac. Pharm. - Senior Pharmacist - is an Antimicrobial Stewardship pharmacist and a clinical researcher with expertise in the establishment of programs for optimising the use of antimicrobials. In addition to being part of the at Queensland Statewide Antimicrobial Stewardship Program she also has affiliations with The University of Queensland Centre for Clinical Research (UQCCR) and the Postgraduate Studies and Professional Development Unit, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne.|
|Emily Waddell, B Pharm – Pharmacist – is an Antimicrobial Stewardship pharmacist with experience in the implementation and delivery of antimicrobial stewardship programs in regional and rural settings.|
|Stacey McNamara, B App Sc, B Nurs, MPH – Clinical Nurse Consultant – is an Antimicrobial Stewardship nurse with experience in acute hospital and community nursing care and education.|
Dr Yannick Emond, FRCPC, DTM&H – Antimicrobial Stewardship Fellow- is an Infectious Diseases and Clinical Microbiologist physician from Montreal, Canada. He is undergoing a one year clinical fellowship in antimicrobial stewardship in conjunction with the Queensland Statewide AMS Program and the Royal Brisbane and Women’s hospital.
|Mr Tyson Byrne-Baxter – Administration Officer – is an Administration Officer for both the Queensland Statewide Antimicrobial Stewardship Program and the Infectious Diseases Unit at the Royal Brisbane and Women’s Hospital.|
Statewide AMS Steering Committee
The Steering Committee provides strategic governance and technical oversight of the Program with the overall aim of promoting the efficacious and safe use of antimicrobials in order to reduce the development of antimicrobial resistance, healthcare associated infections and antimicrobial toxicities.
The steering committee consists of clinician representatives involved in the prescription, dispensing and administration of antimicrobials as well as health care consumers.